NASDAQ
JW (Cayman) Therapeutics Co. Ltd (JWCTF) has a price/sales ratio of 3.79x as of Friday, May 22, 2026. This represents a 91.65% decrease compared to its 12-month average of 45.36x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.